STARLIMS is one of the oldest names in LIMS with one of the most complex ownership histories in the market. Founded in Israel in 1986 by Itschak Friedman and Dinu Toiba, it held an IPO in 2007 and was acquired by Abbott Laboratories in 2009 for $123 million (Wikipedia). Abbott retired the brand for 12 years before Francisco Partners acquired the business in July 2021 and relaunched STARLIMS as an independent brand. In January 2026, Francisco Partners sold STARLIMS to Turn/River Capital — a software-focused private equity firm — per a Business Wire press release dated 13 January 2026. CEO Trey Cook remains in place.
As of April 2026, STARLIMS is a Turn/River Capital portfolio company, headquartered in Hollywood, Florida. It serves more than 1,100 customers across 2,000+ laboratories in 85+ countries (Turn/River press release and LinkedIn), spans life sciences, manufacturing, public health, clinical diagnostics, food & beverage, chemical, oil & gas, and more, and holds the #1 LIMS position on G2 with 158 reviews at 4.5/5 as of the G2 Fall 2025 report.
This article is based on STARLIMS’s official website and press releases, Wikipedia, Business Wire announcements (Labstep acquisition 2023, LPH launch 2024, QM Essentials 2025, Turn/River investment 2026), G2, Capterra, PitchBook, and LinkedIn. STARLIMS has not reviewed, sponsored, or paid for this article.
At a glance
| Field | Details |
| Vendor | STARLIMS Corporation (STARLIMS Technologies) |
| Founded | 1986 in Israel by Itschak Friedman and Dinu Toiba (Wikipedia) |
| HQ | Hollywood, Florida, USA |
| CEO | Trey Cook |
| Employees | ~219 (PitchBook). ~201–500 (LinkedIn). ~85+ countries served. |
| Ownership | Turn/River Capital (PE, investment announced January 2026). Previously Francisco Partners (acquired from Abbott, July 2021). |
| Key corporate history | 1986: Founded (Israel). 2007: IPO. 2009: Acquired by Abbott Labs for $123M. 2021: Sold to Francisco Partners. Aug 2023: Acquired Labstep ELN. Jan 2024: Launched LPH 1.0 (public health LIMS). Oct 2025: Launched QM Essentials (SMB SaaS LIMS). Jan 2026: Sold to Turn/River Capital. |
| Platform scope | LIMS + ELN (Labstep) + LES (Laboratory Execution System) + SDMS (Scientific Data Management System) + Advanced Analytics 2.0 |
| Key industries | Life sciences, pharmaceuticals, CDMOs, food & beverage, chemical & agrochemical, oil & gas, consumer goods, contract testing, public health, clinical diagnostics |
| Named customers | Bayer (14+ years, CropScience regulatory and GxP labs — 2024 Rewind blog). DuPont (R&D lab ecosystem — 2023 Rewind blog). Sasol (manufacturing, 2023). CDC and 12 US state health authorities (by 2005 per Wikipedia). Elypta, Francis Crick Institute (Labstep ELN, starlims.com). Newform Foods (Labstep ELN). |
| Deployment | On-premise, cloud-hosted (managed by STARLIMS), and SaaS. Cloud includes AWS hosting, HIPAA and GDPR compliance, 99.9% availability. QM Essentials is a pure SaaS out-of-the-box product. |
| ELN included | Yes — Labstep (acquired August 2023). Modern cloud R&D ELN sold separately and as part of integrated platform. Also a legacy in-platform ELN (noted in reviews as less user-friendly). |
| Compliance | 21 CFR Part 11, GxP, GMP, GLP, ISO 17025, HIPAA, GDPR. Confirmed on starlims.com and Capterra cloud description. |
| Pricing | Not publicly listed. Enterprise: quote-based. QM Essentials (SMB SaaS): quote-based but deployable in 4–6 weeks. Public sector contracts suggest significant implementation costs for complex deployments. |
| G2 rating | #1 LIMS on G2. 4.5/5 from 158 reviews (G2 Fall 2025 report per STARLIMS blog). Leader in LIMS, SDMS, and ELN Grid reports. Momentum Grid Leader. Mid-market badges in Implementation, Usability, and Relationship indices. |
| Free trial | Not confirmed. |
What STARLIMS does
STARLIMS positions its platform as a unified R&D Quality Manufacturing Informatics Platform — a suite covering the full laboratory value chain from R&D through QC and manufacturing to commercial release. Its core components, all documented on starlims.com and confirmed in Business Wire press releases:
- STARLIMS LIMS: The flagship product. Sample lifecycle management, workflow automation, instrument interfacing, results management, audit trails, electronic signatures, regulatory compliance, and reporting. Supports both simple QC workflows and complex multi-site enterprise deployments. The technology platform (current HTML5 architecture) supports web-based access, mobile data collection, and integration with SAP and other enterprise systems.
- Labstep ELN: Acquired August 2023 (Business Wire). A modern, cloud-native R&D electronic lab notebook with interactive step-by-step protocols, real-time collaboration, inventory management, and version-controlled experiment records. Positioned as a separate product and as the ELN layer in the integrated platform. Key customers on the Labstep page include Elypta (Director of Clinical Development quoted) and Francis Crick Institute (Senior Laboratory Research Scientist quoted).
- SDMS (Scientific Data Management System): Centralised management of instrument data and files. Automates raw data ingestion via file parsing. G2 reviews note SDMS as “susceptible to very minute changes in files for instrument integration and parsing.”
- LES (Laboratory Execution System): Step-by-step electronic batch record execution. Relevant for GMP manufacturing environments.
- Advanced Analytics 2.0: A SaaS, cloud-based analytics and dashboards product launched in 2024. Described on starlims.com as enabling configurable dashboards and deeper data analysis.
- Life Sciences for Public Health (LPH) 1.0: Launched January 2024 (Business Wire). A purpose-built LIMS for public health laboratories, building on STARLIMS’ deep history with CDC and US state health departments. Multi-year roadmap committed.
- QM Essentials: Launched October 2025 (Business Wire). A pre-configured, out-of-the-box SaaS LIMS specifically for small and mid-sized batch manufacturers. Pre-loaded with batch login, environmental monitoring, outsource samples, and static data. Deployable in 4–6 weeks. Targets pharma, food & beverage, and consumer products. This is STARLIMS’s direct answer to the mid-market gap that QBench and CloudLIMS serve.
All modules connect in what STARLIMS calls the R&D Quality Manufacturing Informatics Platform — positioning one vendor as able to support a company from first experiment through to commercial batch release. The 2024 Rewind blog confirms Bayer CropScience as the flagship use case for this end-to-end vision.
| Labstep vs legacy ELN | STARLIMS now has two ELN products: Labstep (the acquired cloud-native R&D product) and an older in-platform ELN. G2 and Capterra reviews reference the legacy ELN as “not very user-friendly” with a reviewer noting STARLIMS is “missing the boat on ELN implementation.” The Labstep product is the current strategic investment and is well-reviewed independently. Labs evaluating STARLIMS for ELN should clarify which product applies to their deployment and whether Labstep is included or priced separately. |
Deployment and compliance
STARLIMS supports three deployment models, confirmed on Capterra and starlims.com:
- On-premise: Customer-managed infrastructure. Full control over update timing. Traditional choice for large enterprises with established IT.
- Cloud-hosted (STARLIMS-managed): Infrastructure on AWS, fully managed by STARLIMS. Includes system monitoring, disaster recovery, HIPAA and GDPR compliance, and 99.9% availability guarantee per the Capterra cloud description.
- SaaS (QM Essentials): Pre-configured, subscription-based product for SMB batch manufacturers. No customisation required to go live.
Compliance standards confirmed on starlims.com and Capterra include: FDA 21 CFR Part 11, GxP (GMP, GLP), ISO 17025, HIPAA, and GDPR. The Capterra cloud offering specifically confirms HIPAA and GDPR as included in the managed cloud tier.
Pricing
STARLIMS does not publish pricing publicly. Enterprise platform pricing requires a direct quote. Two real-world data points from public sector procurement records, cited by an independent Scispot analysis blog:
- State of Michigan: contracted STARLIMS enhancements totalling $202,650 for system upgrades
- Vermont public health lab: approximately $1.7 million implementation with planned lifecycle costs exceeding $2.4 million
These figures are from public sector contracts, which typically reflect competitive bid environments and may not be representative of commercial pricing. They do, however, confirm that complex enterprise STARLIMS implementations involve substantial total cost of ownership. QM Essentials (SMB SaaS) is designed to reduce this — no pricing is published for it either, but its 4–6 week deployment timeframe implies materially lower implementation cost than the enterprise product.
| Pricing note | The only independent pricing signal for STARLIMS in the market comes from public sector procurement disclosures. Commercial pricing is entirely quote-based and will depend heavily on user count, modules selected, deployment model, and implementation scope. Labs should request a total cost of ownership estimate — including implementation, training, and annual support — not just a licence fee. |
Who STARLIMS is designed for
Based on named customers, industry pages, and G2 review profile, STARLIMS is strongest for:
- Large enterprises in pharmaceuticals, food & beverage, chemical, and manufacturing that need an enterprise-grade LIMS with GxP compliance, multi-site global deployment, and SAP integration
- Public health laboratories — STARLIMS’ longest-standing vertical, validated by the CDC and 12 US state deployments (Wikipedia, by 2005) and reinforced by the dedicated LPH 1.0 product launched in 2024
- CDMOs and contract testing organisations that need a configurable platform spanning sample management, batch execution, and regulatory reporting
- Mid-market batch manufacturers (SMBs) now, via QM Essentials — a new entry point launched October 2025 specifically for this segment
- R&D organisations that want to extend LIMS coverage into early research with the Labstep ELN, keeping one vendor across the full value chain
STARLIMS is less commonly the right fit for:
- Small analytical testing labs needing rapid deployment and transparent pricing — QBench or CloudLIMS serve that need more straightforwardly
- Biotech R&D-first organisations focused on molecular biology, CRISPR, and large molecule research — Benchling and Sapio Sciences are better positioned
- Labs that require an ELN as the primary system with LIMS as secondary — SciSure (eLabNext heritage) or Benchling are better fits
What users say
STARLIMS holds G2’s #1 LIMS position with 4.5/5 across 158 reviews (G2 Fall 2025 report). It is also a Leader in G2’s SDMS and ELN categories, and holds the Momentum Grid Leader badge. Mid-market badges were added in Fall 2025 across Implementation, Usability, and Relationship indices. Capterra reviews are more mixed.
Frequently praised
- Comprehensive workflow automation: G2 reviewers consistently cite STARLIMS’ ability to automate complex multi-step lab workflows. One G2 reviewer notes it “automated many of the complex lab workflows and reduced the need to work with multiple small applications such as Excel and different databases.”
- Audit trail and compliance: Audit trails are cited by multiple G2 reviewers as a core strength. One reviewer specifically praises “audit trail for each event in STARLIMS” as a primary benefit.
- Instrument integration: Capterra reviewers highlight the instrument interface as a key strength. One reviewer states “the instrument interface is the best part, really useful. I can use it for any kind of instrument.”
- G2 performance vs LabVantage and Thermo Scientific: STARLIMS’ own comparison content cites G2 reviewers as preferring STARLIMS over Thermo Scientific for data access controls and over LabVantage for workflow management interface. These comparisons are vendor-authored but draw on G2 review language.
Frequently criticised
- Steep learning curve and mandatory training: Capterra reviewers note that STARLIMS “is an effective sample management option, but training to use it is absolutely required.” The platform is not designed for self-guided setup.
- SDMS and legacy ELN usability: G2 reviewers flag that “SDMS and ELN components are not very user-friendly and come with certain limitations.” SDMS is described as “susceptible to very minute changes in files for instrument integration and parsing.”
- Customisation requirement for out-of-the-box use: Capterra reviewers — including one user forced to adopt STARLIMS — describe significant customisation requirements for analytical laboratories, characterising the default configuration as poorly suited to basic LIMS functions without extensive modification.
- Performance: G2 reviewers note that the Results Entry module “takes significant time to perform manual results entry” and that SDMS upload times require multiple refreshes.
Quick verdict
| Best for | Enterprise laboratories in pharmaceuticals, manufacturing, CDMOs, food & beverage, chemical, and public health that need a globally proven, compliance-ready LIMS with 35+ years of deployment track record across multi-site operations. STARLIMS’ public health vertical — validated by CDC and state health departments — is unmatched in this series. The unified platform covering LIMS, LES, SDMS, ELN, and Advanced Analytics gives large organisations a single vendor from R&D through batch release. The G2 #1 LIMS ranking across 158 reviews confirms broad enterprise satisfaction. |
| Consider alternatives if | Your lab needs rapid deployment without extensive customisation, transparent pricing, or a modern SaaS UX. For SMB analytical testing, QBench or CloudLIMS offer faster time-to-value. For biotech R&D and molecular biology, Benchling or Sapio Sciences are more purpose-built. STARLIMS’ QM Essentials (launched October 2025) is its own answer to the SMB gap, but is too new to have an established user review base. |
Further reading
- STARLIMS official website
- STARLIMS on G2 — 158 reviews, 4.5/5
- STARLIMS on Capterra
- Turn/River Capital investment — Business Wire, January 2026
- STARLIMS acquires Labstep ELN — Business Wire, August 2023
- STARLIMS QM Essentials launch — Business Wire, October 2025
- Life Sciences for Public Health (LPH) 1.0 launch — Business Wire, January 2024
- STARLIMS — Wikipedia
- labsoftwareguide.com: ISO 17025 and LIMS
- labsoftwareguide.com: Best LIMS Software 2026
| Editorial note | This article is based on: STARLIMS’ official website; Wikipedia; Business Wire press releases (Labstep acquisition August 2023, LPH 1.0 January 2024, QM Essentials October 2025, Turn/River Capital January 2026); STARLIMS’ own 2023 and 2024 Rewind blog posts; STARLIMS’ G2 rankings blog posts; G2; Capterra; PitchBook; LinkedIn; LeadIQ; and the Scispot STARLIMS pricing blog (competitor-authored; public sector contract figures attributed to that source and caveated). Named customer references are attributed to the source in which they appear. STARLIMS has not reviewed, sponsored, or paid for this article. Last verified: April 2026. |


